DK3286209T3 - Fremgangsmåde til fremstilling af gonadotrophin - Google Patents

Fremgangsmåde til fremstilling af gonadotrophin Download PDF

Info

Publication number
DK3286209T3
DK3286209T3 DK16721722.3T DK16721722T DK3286209T3 DK 3286209 T3 DK3286209 T3 DK 3286209T3 DK 16721722 T DK16721722 T DK 16721722T DK 3286209 T3 DK3286209 T3 DK 3286209T3
Authority
DK
Denmark
Prior art keywords
gonadotrophine
production procedure
procedure
production
gonadotrophine production
Prior art date
Application number
DK16721722.3T
Other languages
English (en)
Inventor
Daniel Plaksin
Ayelet Grinhut
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3286209T3 publication Critical patent/DK3286209T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1081Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/99Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C12Y204/99004Beta-galactoside alpha-2,3-sialyltransferase (2.4.99.4)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host
DK16721722.3T 2015-04-24 2016-04-22 Fremgangsmåde til fremstilling af gonadotrophin DK3286209T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15164965 2015-04-24
PCT/EP2016/059006 WO2016170113A1 (en) 2015-04-24 2016-04-22 Method of production of gonadotrophin

Publications (1)

Publication Number Publication Date
DK3286209T3 true DK3286209T3 (da) 2020-12-21

Family

ID=53002568

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16721722.3T DK3286209T3 (da) 2015-04-24 2016-04-22 Fremgangsmåde til fremstilling af gonadotrophin

Country Status (31)

Country Link
US (1) US10464984B2 (da)
EP (1) EP3286209B1 (da)
JP (1) JP6964519B2 (da)
CN (2) CN114107315A (da)
AU (1) AU2016251314B2 (da)
BR (1) BR112017016895A2 (da)
CA (1) CA2975449A1 (da)
CL (1) CL2017002661A1 (da)
CO (1) CO2017011964A2 (da)
DK (1) DK3286209T3 (da)
EA (1) EA034022B1 (da)
ES (1) ES2837111T3 (da)
HK (1) HK1246325A1 (da)
HR (1) HRP20201945T1 (da)
HU (1) HUE051879T2 (da)
IL (1) IL253694B (da)
LT (1) LT3286209T (da)
MA (1) MA41949B1 (da)
MD (1) MD3286209T2 (da)
MX (1) MX2017010884A (da)
MY (1) MY185823A (da)
PH (1) PH12017501585A1 (da)
PT (1) PT3286209T (da)
RS (1) RS61163B1 (da)
SA (1) SA517390029B1 (da)
SG (1) SG11201706832PA (da)
SI (1) SI3286209T1 (da)
TN (1) TN2017000328A1 (da)
UA (1) UA124187C2 (da)
WO (1) WO2016170113A1 (da)
ZA (1) ZA201707136B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3675894T (lt) 2017-09-01 2021-12-10 Ferring B.V. Kompozicija, skirta kontroliuojamam kiaušidžių stimuliavimui
CN108264549A (zh) * 2018-03-29 2018-07-10 北京伟杰信生物科技有限公司 重组绒促性素rhCG的制备方法及应用
US20210038694A1 (en) 2018-04-30 2021-02-11 Ferring B.V. Composition for controlled ovarian stimulation
CN110812366B (zh) * 2019-11-18 2023-11-17 珠海丽凡达生物技术有限公司 一种可用于激素补充的mRNA药物及其制备方法
CN113337562B (zh) * 2021-05-24 2022-06-03 宁波人健药业集团股份有限公司 使用CHO细胞高效发酵生产rhCG的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855544B1 (en) 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
AU2001231531A1 (en) * 2000-02-11 2001-08-20 Maxygen Aps Follicle stimulating hormones
US20030036181A1 (en) 2000-06-30 2003-02-20 Okkels Jens Sigurd Peptide extended glycosylated polypeptides
CN1194016C (zh) * 2000-12-29 2005-03-23 申庆祥 新的人绒毛膜促性腺激素-促黄体素融合蛋白及其制法和用途
CN101250531B (zh) * 2006-11-27 2013-04-24 株式会社Lg生命科学 一核苷酸序列、包含该序列的表达载体、该载体转化的动物细胞及利用该细胞生产人fsh的方法
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
US8326547B2 (en) * 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
WO2011084145A2 (en) 2009-12-21 2011-07-14 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
EP2833923A4 (en) 2012-04-02 2016-02-24 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
CN108949772A (zh) * 2012-04-02 2018-12-07 现代泰克斯公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
CN103539862B (zh) * 2013-11-01 2015-04-01 广州联康生物科技有限公司 一种长效重组促卵泡激素及其应用

Also Published As

Publication number Publication date
AU2016251314B2 (en) 2019-12-05
ZA201707136B (en) 2022-03-30
EA201791724A1 (ru) 2018-04-30
ES2837111T3 (es) 2021-06-29
UA124187C2 (uk) 2021-08-04
SA517390029B1 (ar) 2021-04-04
SG11201706832PA (en) 2017-09-28
MA41949B1 (fr) 2020-12-31
MY185823A (en) 2021-06-11
RS61163B1 (sr) 2021-01-29
IL253694A0 (en) 2017-09-28
CO2017011964A2 (es) 2018-03-09
CN107532172A (zh) 2018-01-02
IL253694B (en) 2021-09-30
MD3286209T2 (ro) 2021-04-30
PT3286209T (pt) 2020-12-04
SI3286209T1 (sl) 2021-01-29
EA034022B1 (ru) 2019-12-19
JP6964519B2 (ja) 2021-11-10
HK1246325A1 (zh) 2018-09-07
EP3286209B1 (en) 2020-11-25
CA2975449A1 (en) 2016-10-27
AU2016251314A1 (en) 2017-08-17
CN114107315A (zh) 2022-03-01
WO2016170113A1 (en) 2016-10-27
HUE051879T2 (hu) 2021-03-29
CL2017002661A1 (es) 2018-03-23
PH12017501585A1 (en) 2018-02-05
EP3286209A1 (en) 2018-02-28
US10464984B2 (en) 2019-11-05
JP2018512885A (ja) 2018-05-24
MX2017010884A (es) 2017-12-07
BR112017016895A2 (pt) 2018-03-27
US20180127477A1 (en) 2018-05-10
MA41949A (fr) 2018-02-28
HRP20201945T1 (hr) 2021-02-05
TN2017000328A1 (en) 2019-01-16
LT3286209T (lt) 2021-02-25
KR20170138390A (ko) 2017-12-15

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3126373T3 (da) Fremgangsmåde til fremstilling af amg 416
DK3341479T3 (da) LNA-G-Proces
DK3270930T3 (da) Præeklampsi
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3286209T3 (da) Fremgangsmåde til fremstilling af gonadotrophin
DK3314597T3 (da) Fjernstyring
NO2023044I1 (no) capromorelin
DE112015006486A5 (de) Inkubationsrinne
DK3166923T3 (da) Fremgangsmåde til fremstilling af substituerede phenylalkaner
DK3295941T3 (da) Fremgangsmåde til fremstilling af form a af grapiprant
DK3365629T3 (da) H-formet vaterpas
DK3148993T3 (da) Fremgangsmåde til fremstilling af thiazolderivater
DK3149422T3 (da) Anordning til fremstilling af cementklinker
DE112016005599A5 (de) Strahlungsgrill
DK3247700T3 (da) Fremgangsmåde til fremstilling af en polyumættet ketonforbindelse
DK3259549T3 (da) Lyssporammunition
DE112015005906A5 (de) Gurtschlossbringer
DK3161136T3 (da) Fremgangsmåde til berigelse af mikrovesikler
DE102015206660A8 (de) Plattenaufteilanlage